{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:57:02Z","timestamp":1791561422591,"version":"4.3.4"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"CSRA Parkinson Support Group","award":["PSG00037"],"award-info":[{"award-number":["PSG00037"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s11011-021-00735-2","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T08:05:18Z","timestamp":1618992318000},"page":"1687-1696","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Emerging urinary alpha-synuclein and miRNA biomarkers in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8935-7588","authenticated-orcid":false,"given":"Banabihari","family":"Giri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa","family":"Seamon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharad","family":"Purohit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak","family":"Baban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandramohan","family":"Wakade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,21]]},"reference":[{"key":"735_CR1","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature02871","volume":"431","author":"V Ambros","year":"2004","unstructured":"Ambros V (2004) The functions of animal microRNAs. Nature 431:350\u2013355. https:\/\/doi.org\/10.1038\/nature02871","journal-title":"Nature"},{"key":"735_CR2","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/bpa.12370","volume":"26","author":"A Atik","year":"2016","unstructured":"Atik A, Stewart T, Zhang J (2016) Alpha-Synuclein as a biomarker for Parkinson's disease. Brain Pathol 26:410\u2013418. https:\/\/doi.org\/10.1111\/bpa.12370","journal-title":"Brain Pathol"},{"key":"735_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/mds.870130205","volume":"13","author":"RB Banati","year":"1998","unstructured":"Banati RB, Daniel SE, Blunt SB (1998) Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society 13:221\u2013227. https:\/\/doi.org\/10.1002\/mds.870130205","journal-title":"Movement disorders : official journal of the Movement Disorder Society"},{"key":"735_CR4","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.5213\/inj.1612720.360","volume":"20","author":"A Beasley-Green","year":"2016","unstructured":"Beasley-Green A (2016) Urine proteomics in the era of mass spectrometry. Int Neurourol J 20:S70\u2013S75. https:\/\/doi.org\/10.5213\/inj.1612720.360","journal-title":"Int Neurourol J"},{"key":"735_CR5","doi-asserted-by":"publisher","unstructured":"Beck KE, Kay JG, Braun JE (2006) Rdj2, a J protein family member, interacts with cellular prion PrP(C) biochemical and biophysical research communications 346:866-871 doi:https:\/\/doi.org\/10.1016\/j.bbrc.2006.05.185","DOI":"10.1016\/j.bbrc.2006.05.185"},{"key":"735_CR6","doi-asserted-by":"publisher","first-page":"4271","DOI":"10.1111\/j.1742-4658.2008.06563.x","volume":"275","author":"NP Bhattacharyya","year":"2008","unstructured":"Bhattacharyya NP, Banerjee M, Majumder P (2008) Huntington's disease: roles of huntingtin-interacting protein 1 (HIP-1) and its molecular partner HIPPI in the regulation of apoptosis and transcription. FEBS J 275:4271\u20134279. https:\/\/doi.org\/10.1111\/j.1742-4658.2008.06563.x","journal-title":"FEBS J"},{"key":"735_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073076","volume":"8","author":"S Bouatra","year":"2013","unstructured":"Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, Bjorndahl TC, Krishnamurthy R, Saleem F, Liu P, Dame ZT, Poelzer J, Huynh J, Yallou FS, Psychogios N, Dong E, Bogumil R, Roehring C, Wishart DS (2013) The human urine metabolome. PLoS One 8:e73076. https:\/\/doi.org\/10.1371\/journal.pone.0073076","journal-title":"PLoS One"},{"key":"735_CR8","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1038\/nm1202-802","volume":"8","author":"JT Brindle","year":"2002","unstructured":"Brindle JT, Antti H, Holmes E, Tranter G, Nicholson JK, Bethell HWL, Clarke S, Schofield PM, McKilligin E, Mosedale DE, Grainger DJ (2002) Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med 8:1439\u20131444. https:\/\/doi.org\/10.1038\/nm1202-802","journal-title":"Nat Med"},{"key":"735_CR9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.neulet.2018.12.030","volume":"696","author":"Z Cao","year":"2019","unstructured":"Cao Z, Wu Y, Liu G, Jiang Y, Wang X, Wang Z, Feng T (2019) Alpha-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson's disease. Neurosci Lett 696:114\u2013120. https:\/\/doi.org\/10.1016\/j.neulet.2018.12.030","journal-title":"Neurosci Lett"},{"key":"735_CR10","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1038\/nprot.2011.375","volume":"6","author":"EC Chan","year":"2011","unstructured":"Chan EC, Pasikanti KK, Nicholson JK (2011) Global urinary metabolic profiling procedures using gas chromatography-mass spectrometry. Nat Protoc 6:1483\u20131499. https:\/\/doi.org\/10.1038\/nprot.2011.375","journal-title":"Nat Protoc"},{"key":"735_CR11","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.3389\/fneur.2019.01388","volume":"10","author":"CW Chang","year":"2019","unstructured":"Chang CW, Yang SY, Yang CC, Chang CW, Wu YR (2019) Plasma and serum alpha-Synuclein as a biomarker of diagnosis in patients with Parkinson's disease. Front Neurol 10:1388. https:\/\/doi.org\/10.3389\/fneur.2019.01388","journal-title":"Front Neurol"},{"key":"735_CR12","doi-asserted-by":"publisher","unstructured":"Chen NC et al. (2020) Plasma levels of alpha-Synuclein, Abeta-40 and T-tau as biomarkers to predict cognitive impairment in Parkinson's disease front aging Neurosci 12:112 doi:https:\/\/doi.org\/10.3389\/fnagi.2020.00112","DOI":"10.3389\/fnagi.2020.00112"},{"key":"735_CR13","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/mp.2014.127","volume":"20","author":"L Cheng","year":"2015","unstructured":"Cheng L et al (2015) Prognostic serum miRNA biomarkers associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessment. Mol Psychiatry 20:1188\u20131196. https:\/\/doi.org\/10.1038\/mp.2014.127","journal-title":"Mol Psychiatry"},{"key":"735_CR14","unstructured":"Chou KL (2016) Clinical manifestations of Parkinson disease"},{"key":"735_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2147\/IJNRD.S37885","volume":"6","author":"AC Chung","year":"2013","unstructured":"Chung AC, Yu X, Lan HY (2013) MicroRNA and nephropathy: emerging concepts. Int J Nephrol Renovasc Dis 6:169\u2013179. https:\/\/doi.org\/10.2147\/IJNRD.S37885","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"735_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr015","volume":"134","author":"I Devic","year":"2011","unstructured":"Devic I, Hwang HJ, Edgar JS, Izutsu K, Presland R, Pan C, Goodlett DR, Wang Y, Armaly J, Tumas V, Zabetian CP, Leverenz JB, Shi M, Zhang J (2011) Salivary alpha-synuclein and DJ-1: potential biomarkers for Parkinson's disease. Brain : a journal of neurology 134:e178. https:\/\/doi.org\/10.1093\/brain\/awr015","journal-title":"Brain : a journal of neurology"},{"key":"735_CR17","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1038\/ni.1798","volume":"10","author":"C Du","year":"2009","unstructured":"Du C et al (2009) MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol 10:1252\u20131259. https:\/\/doi.org\/10.1038\/ni.1798","journal-title":"Nat Immunol"},{"key":"735_CR18","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nrg2290","volume":"9","author":"W Filipowicz","year":"2008","unstructured":"Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9:102\u2013114. https:\/\/doi.org\/10.1038\/nrg2290","journal-title":"Nat Rev Genet"},{"key":"735_CR19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.sbi.2005.05.006","volume":"15","author":"W Filipowicz","year":"2005","unstructured":"Filipowicz W, Jaskiewicz L, Kolb FA, Pillai RS (2005) Post-transcriptional gene silencing by siRNAs and miRNAs. Curr Opin Struct Biol 15:331\u2013341. https:\/\/doi.org\/10.1016\/j.sbi.2005.05.006","journal-title":"Curr Opin Struct Biol"},{"key":"735_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neulet.2018.03.037","volume":"675","author":"L Geng","year":"2018","unstructured":"Geng L, Zhang T, Liu W, Chen Y (2018) miR-494-3p modulates the progression of in vitro and in vivo Parkinson's disease models by targeting SIRT3. Neurosci Lett 675:23\u201330. https:\/\/doi.org\/10.1016\/j.neulet.2018.03.037","journal-title":"Neurosci Lett"},{"key":"735_CR21","doi-asserted-by":"publisher","unstructured":"Giri B, Belanger K, Seamon M, Bradley E, Purohit S, Chong R, Morgan JC, Baban B, Wakade C (2019) Niacin ameliorates Neuro-inflammation in Parkinson's disease via GPR109A. Int J Mol Sci 20. https:\/\/doi.org\/10.3390\/ijms20184559","DOI":"10.3390\/ijms20184559"},{"key":"735_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jneuroim.2011.10.006","volume":"248","author":"M Guerau-de-Arellano","year":"2012","unstructured":"Guerau-de-Arellano M, Alder H, Ozer HG, Lovett-Racke A, Racke MK (2012) miRNA profiling for biomarker discovery in multiple sclerosis: from microarray to deep sequencing. J Neuroimmunol 248:32\u201339. https:\/\/doi.org\/10.1016\/j.jneuroim.2011.10.006","journal-title":"J Neuroimmunol"},{"key":"735_CR23","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/clinchem\/40.6.862","volume":"40","author":"F Guneral","year":"1994","unstructured":"Guneral F, Bachmann C (1994) Age-related reference values for urinary organic acids in a healthy Turkish pediatric population. Clin Chem 40:862\u2013866","journal-title":"Clin Chem"},{"issue":"6","key":"735_CR24","first-page":"6","volume":"28","author":"MHK Hanke","year":"2010","unstructured":"Hanke MHK, Merz H, Feller AC, Kausch I, Jocham D, Warnecke JM, Sczakiel G (2010) A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. Jurolonc 28(6):6","journal-title":"Jurolonc"},{"key":"735_CR25","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.2174\/1389201021666200420101613","volume":"21","author":"A Hashemi","year":"2020","unstructured":"Hashemi A, Gorji-Bahri G (2020) MicroRNA: promising roles in Cancer therapy. Curr Pharm Biotechnol 21:1186\u20131203. https:\/\/doi.org\/10.2174\/1389201021666200420101613","journal-title":"Curr Pharm Biotechnol"},{"key":"735_CR26","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/j.1749-6632.2003.tb07478.x","volume":"991","author":"EC Hirsch","year":"2003","unstructured":"Hirsch EC, Breidert T, Rousselet E, Hunot S, Hartmann A, Michel PP (2003) The role of glial reaction and inflammation in Parkinson's disease. Ann N Y Acad Sci 991:214\u2013228","journal-title":"Ann N Y Acad Sci"},{"key":"735_CR27","doi-asserted-by":"publisher","first-page":"704678","DOI":"10.1155\/2014\/704678","volume":"2014","author":"DH Ho","year":"2014","unstructured":"Ho DH, Yi S, Seo H, Son I, Seol W (2014) Increased DJ-1 in urine exosome of Korean males with Parkinson's disease. Biomed Res Int 2014:704678\u2013704678. https:\/\/doi.org\/10.1155\/2014\/704678","journal-title":"Biomed Res Int"},{"key":"735_CR28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.conb.2017.12.008","volume":"48","author":"JY Hwang","year":"2018","unstructured":"Hwang JY, Zukin RS (2018) REST, a master transcriptional regulator in neurodegenerative disease. Curr Opin Neurobiol 48:193\u2013200. https:\/\/doi.org\/10.1016\/j.conb.2017.12.008","journal-title":"Curr Opin Neurobiol"},{"key":"735_CR29","first-page":"8","volume":"7","author":"KM Ioanna Chalatsa","year":"2020","unstructured":"Ioanna Chalatsa KM, Emmanouilidou E, Vekrellis K (2020) Assessment of cerebrospinal fluid \u03b1-synuclein as a potential biomarker in Parkinson\u2019s disease and synucleinopathies. Neuroimmunol Neuroinflammation 7:8","journal-title":"Neuroimmunol Neuroinflammation"},{"key":"735_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/s0304-3940(98)00599-0","volume":"253","author":"MW Jakowec","year":"1998","unstructured":"Jakowec MW, Petzinger GM, Sastry S, Donaldson DM, McCormack A, Langston JW (1998) The native form of alpha-synuclein is not found in the cerebrospinal fluid of patients with Parkinson's disease or normal controls. Neurosci Lett 253:13\u201316. https:\/\/doi.org\/10.1016\/s0304-3940(98)00599-0","journal-title":"Neurosci Lett"},{"key":"735_CR31","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s11033-020-06050-w","volume":"48","author":"JA Jimenez-Avalos","year":"2020","unstructured":"Jimenez-Avalos JA, Fernandez-Macias JC, Gonzalez-Palomo AK (2020) Circulating exosomal MicroRNAs: new non-invasive biomarkers of non-communicable disease. Mol Biol Rep 48:961\u2013967. https:\/\/doi.org\/10.1007\/s11033-020-06050-w","journal-title":"Mol Biol Rep"},{"key":"735_CR32","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.nbd.2007.11.001","volume":"29","author":"R Johnson","year":"2008","unstructured":"Johnson R, Zuccato C, Belyaev ND, Guest DJ, Cattaneo E, Buckley NJ (2008) A microRNA-based gene dysregulation pathway in Huntington's disease. Neurobiol Dis 29:438\u2013445. https:\/\/doi.org\/10.1016\/j.nbd.2007.11.001","journal-title":"Neurobiol Dis"},{"key":"735_CR33","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/ana.23746","volume":"73","author":"LV Kalia","year":"2013","unstructured":"Kalia LV, Kalia SK, McLean PJ, Lozano AM, Lang AE (2013) Alpha-Synuclein oligomers and clinical implications for Parkinson disease. Ann Neurol 73:155\u2013169. https:\/\/doi.org\/10.1002\/ana.23746","journal-title":"Ann Neurol"},{"key":"735_CR34","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/mds.25499","volume":"28","author":"M Kasten","year":"2013","unstructured":"Kasten M, Klein C (2013) The many faces of alpha-synuclein mutations. Movement disorders : official journal of the Movement Disorder Society 28:697\u2013701. https:\/\/doi.org\/10.1002\/mds.25499","journal-title":"Movement disorders : official journal of the Movement Disorder Society"},{"key":"735_CR35","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1093\/brain\/awq059","volume":"133","author":"PA Kempster","year":"2010","unstructured":"Kempster PA, O'Sullivan SS, Holton JL, Revesz T, Lees AJ (2010) Relationships between age and late progression of Parkinson's disease: a clinico-pathological study. Brain : a journal of neurology 133:1755\u20131762. https:\/\/doi.org\/10.1093\/brain\/awq059","journal-title":"Brain : a journal of neurology"},{"key":"735_CR36","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1126\/science.1140481","volume":"317","author":"J Kim","year":"2007","unstructured":"Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, Murchison E, Hannon G, Abeliovich A (2007) A MicroRNA feedback circuit in midbrain dopamine neurons. Science 317:1220\u20131224. https:\/\/doi.org\/10.1126\/science.1140481","journal-title":"Science"},{"key":"735_CR37","doi-asserted-by":"publisher","first-page":"160022","DOI":"10.1098\/rsob.160022","volume":"6","author":"P Koukouraki","year":"2016","unstructured":"Koukouraki P, Doxakis E (2016) Constitutive translation of human alpha-synuclein is mediated by the 5\u2032-untranslated region. Open Biol 6:160022. https:\/\/doi.org\/10.1098\/rsob.160022","journal-title":"Open Biol"},{"key":"735_CR38","doi-asserted-by":"publisher","unstructured":"Kume K et al (2018) Serum microRNA expression profiling in patients with multiple system atrophy Mol med rep 17:852-860. https:\/\/doi.org\/10.3892\/mmr.2017.7995","DOI":"10.3892\/mmr.2017.7995"},{"key":"735_CR39","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1002\/emmm.201201974","volume":"5","author":"P Lau","year":"2013","unstructured":"Lau P, Bossers K, Janky R', Salta E, Frigerio CS, Barbash S, Rothman R, Sierksma ASR, Thathiah A, Greenberg D, Papadopoulou AS, Achsel T, Ayoubi T, Soreq H, Verhaagen J, Swaab DF, Aerts S, de Strooper B (2013) Alteration of the microRNA network during the progression of Alzheimer's disease. EMBO Mol Med 5:1613\u20131634. https:\/\/doi.org\/10.1002\/emmm.201201974","journal-title":"EMBO Mol Med"},{"key":"735_CR40","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s00702-005-0427-9","volume":"113","author":"PH Lee","year":"2006","unstructured":"Lee PH, Lee G, Park HJ, Bang OY, Joo IS, Huh K (2006) The plasma alpha-synuclein levels in patients with Parkinson's disease and multiple system atrophy. J Neural Transm 113:1435\u20131439. https:\/\/doi.org\/10.1007\/s00702-005-0427-9","journal-title":"J Neural Transm"},{"key":"735_CR41","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s12035-014-8788-4","volume":"51","author":"ST Lee","year":"2015","unstructured":"Lee ST, Chu K, Jung KH, Ban JJ, Im WS, Jo HY, Park JH, Lim JY, Shin JW, Moon J, Lee SK, Kim M, Roh JK (2015) Altered expression of miR-202 in cerebellum of multiple-system atrophy. Mol Neurobiol 51:180\u2013186. https:\/\/doi.org\/10.1007\/s12035-014-8788-4","journal-title":"Mol Neurobiol"},{"key":"735_CR42","doi-asserted-by":"publisher","DOI":"10.1063\/1.4996768","volume":"11","author":"E Lepowsky","year":"2017","unstructured":"Lepowsky E, Ghaderinezhad F, Knowlton S, Tasoglu S (2017) Paper-based assays for urine analysis. Biomicrofluidics 11:051501. https:\/\/doi.org\/10.1063\/1.4996768","journal-title":"Biomicrofluidics"},{"key":"735_CR43","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","volume":"120","author":"BP Lewis","year":"2005","unstructured":"Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15\u201320. https:\/\/doi.org\/10.1016\/j.cell.2004.12.035","journal-title":"Cell"},{"key":"735_CR44","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1126\/science.1080372","volume":"299","author":"LP Lim","year":"2003","unstructured":"Lim LP, Glasner ME, Yekta S, Burge CB, Bartel DP (2003) Vertebrate microRNA genes. Science 299:1540. https:\/\/doi.org\/10.1126\/science.1080372","journal-title":"Science"},{"key":"735_CR45","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1136\/jnnp-2016-314857","volume":"88","author":"CH Lin","year":"2017","unstructured":"Lin CH, Yang SY, Horng HE, Yang CC, Chieh JJ, Chen HH, Liu BH, Chiu MJ (2017) Plasma alpha-synuclein predicts cognitive decline in Parkinson's disease. J Neurol Neurosurg Psychiatry 88:818\u2013824. https:\/\/doi.org\/10.1136\/jnnp-2016-314857","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"735_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047387","volume":"7","author":"D Lindqvist","year":"2012","unstructured":"Lindqvist D, Kaufman E, Brundin L, Hall S, Surova Y, Hansson O (2012) Non-motor symptoms in patients with Parkinson's disease - correlations with inflammatory cytokines in serum. PLoS One 7:e47387. https:\/\/doi.org\/10.1371\/journal.pone.0047387","journal-title":"PLoS One"},{"key":"735_CR47","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/1746-1596-8-158","volume":"8","author":"F Liu","year":"2013","unstructured":"Liu F, Xiong Y, Zhao Y, Tao L, Zhang Z, Zhang H, Liu Y, Feng G, Li B, He L, Ma J, Qin S, Yang Y (2013) Identification of aberrant microRNA expression pattern in pediatric gliomas by microarray. Diagn Pathol 8:158. https:\/\/doi.org\/10.1186\/1746-1596-8-158","journal-title":"Diagn Pathol"},{"key":"735_CR48","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10571-015-0317-0","volume":"36","author":"C Loov","year":"2016","unstructured":"Loov C, Scherzer CR, Hyman BT, Breakefield XO, Ingelsson M (2016) Alpha-Synuclein in extracellular vesicles: functional implications and diagnostic opportunities. Cell Mol Neurobiol 36:437\u2013448. https:\/\/doi.org\/10.1007\/s10571-015-0317-0","journal-title":"Cell Mol Neurobiol"},{"key":"735_CR49","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1158\/1055-9965.EPI-11-0035","volume":"20","author":"X Luo","year":"2011","unstructured":"Luo X, Burwinkel B, Tao S, Brenner H (2011) MicroRNA signatures: novel biomarker for colorectal cancer? Cancer Epidemiol Biomark Prev 20:1272\u20131286. https:\/\/doi.org\/10.1158\/1055-9965.EPI-11-0035","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"735_CR50","doi-asserted-by":"publisher","unstructured":"Mancuso R, Agostini S, Hernis A, Zanzottera M, Bianchi A, Clerici M (2019) Circulatory miR-223-3p discriminates between Parkinson's and Alzheimer's patients scientific reports 9:9393 doi:https:\/\/doi.org\/10.1038\/s41598-019-45687-x","DOI":"10.1038\/s41598-019-45687-x"},{"key":"735_CR51","doi-asserted-by":"publisher","first-page":"7219","DOI":"10.1093\/nar\/gkq575","volume":"38","author":"E Marti","year":"2010","unstructured":"Marti E et al (2010) A myriad of miRNA variants in control and Huntington's disease brain regions detected by massively parallel sequencing. Nucleic Acids Res 38:7219\u20137235. https:\/\/doi.org\/10.1093\/nar\/gkq575","journal-title":"Nucleic Acids Res"},{"key":"735_CR52","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38:1285\u20131291","journal-title":"Neurology"},{"key":"735_CR53","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.healun.2015.01.979","volume":"34","author":"SD Miyamoto","year":"2015","unstructured":"Miyamoto SD, Karimpour-Fard A, Peterson V, Auerbach SR, Stenmark KR, Stauffer BL, Sucharov CC (2015) Circulating microRNA as a biomarker for recovery in pediatric dilated cardiomyopathy. J Heart Lung Transplant 34:724\u2013733. https:\/\/doi.org\/10.1016\/j.healun.2015.01.979","journal-title":"J Heart Lung Transplant"},{"key":"735_CR54","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/jnc.14569","volume":"149","author":"B Mollenhauer","year":"2019","unstructured":"Mollenhauer B, Bowman FDB, Drake D, Duong J, Blennow K, el-Agnaf O, Shaw LM, Masucci J, Taylor P, Umek RM, Dunty JM, Smith CL, Stoops E, Vanderstichele H, Schmid AW, Moniatte M, Zhang J, Kruse N, Lashuel HA, Teunissen C, Schubert T, Dave KD, Hutten SJ, Zetterberg H (2019a) Antibody-based methods for the measurement of alpha-synuclein concentration in human cerebrospinal fluid - method comparison and round robin study. J Neurochem 149:126\u2013138. https:\/\/doi.org\/10.1111\/jnc.14569","journal-title":"J Neurochem"},{"key":"735_CR55","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1002\/mds.27806","volume":"34","author":"B Mollenhauer","year":"2019","unstructured":"Mollenhauer B, Caspell-Garcia CJ, Coffey CS, Taylor P, Singleton A, Shaw LM, Trojanowski JQ, Frasier M, Simuni T, Iranzo A, Oertel W, Siderowf A, Weintraub D, Seibyl J, Toga AW, Tanner CM, Kieburtz K, Chahine LM, Marek K, Galasko D, for the PPMI study (2019b) Longitudinal analyses of cerebrospinal fluid alpha-Synuclein in prodromal and early Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society 34:1354\u20131364. https:\/\/doi.org\/10.1002\/mds.27806","journal-title":"Movement disorders : official journal of the Movement Disorder Society"},{"key":"735_CR56","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S1474-4422(11)70014-X","volume":"10","author":"B Mollenhauer","year":"2011","unstructured":"Mollenhauer B, Locascio JJ, Schulz-Schaeffer W, Sixel-Doring F, Trenkwalder C, Schlossmacher MG (2011) Alpha-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. Lancet Neurol 10:230\u2013240. https:\/\/doi.org\/10.1016\/S1474-4422(11)70014-X","journal-title":"Lancet Neurol"},{"key":"735_CR57","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/mds.27492","volume":"34","author":"B Mollenhauer","year":"2019","unstructured":"Mollenhauer B, Zimmermann J, Sixel-D\u00f6ring F, Focke NK, Wicke T, Ebentheuer J, Schaumburg M, Lang E, Friede T, Trenkwalder C, on behalf of the DeNoPa Study Group (2019c) Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De novo Parkinson cohort (DeNoPa). Movement disorders : official journal of the Movement Disorder Society 34:67\u201377. https:\/\/doi.org\/10.1002\/mds.27492","journal-title":"Movement disorders : official journal of the Movement Disorder Society"},{"key":"735_CR58","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1750-1326-4-36","volume":"4","author":"J Montag","year":"2009","unstructured":"Montag J, Hitt R, Opitz L, Schulz-Schaeffer WJ, Hunsmann G, Motzkus D (2009) Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease. Mol Neurodegener 4:36. https:\/\/doi.org\/10.1186\/1750-1326-4-36","journal-title":"Mol Neurodegener"},{"key":"735_CR59","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.nbd.2011.12.046","volume":"46","author":"MM Mouradian","year":"2012","unstructured":"Mouradian MM (2012) MicroRNAs in Parkinson's disease. Neurobiol Dis 46:279\u2013284. https:\/\/doi.org\/10.1016\/j.nbd.2011.12.046","journal-title":"Neurobiol Dis"},{"key":"735_CR60","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.neurobiolaging.2013.07.005","volume":"35","author":"M Muller","year":"2014","unstructured":"Muller M, Kuiperij HB, Claassen JA, Kusters B, Verbeek MM (2014) MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid. Neurobiol Aging 35:152\u2013158. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.07.005","journal-title":"Neurobiol Aging"},{"key":"735_CR61","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3233\/JPD-201983","volume":"10","author":"D Nam","year":"2020","unstructured":"Nam D, Lee JY, Lee M, Kim J, Seol W, Son I, Ho DH (2020) Detection and assessment of alpha-Synuclein oligomers in the urine of Parkinson's disease patients. J Parkinsons Dis 10:981\u2013991. https:\/\/doi.org\/10.3233\/JPD-201983","journal-title":"J Parkinsons Dis"},{"key":"735_CR62","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1750-3639.2007.00120.x","volume":"18","author":"PT Nelson","year":"2008","unstructured":"Nelson PT, Wang WX, Rajeev BW (2008) MicroRNAs (miRNAs) in neurodegenerative diseases. Brain Pathol 18:130\u2013138. https:\/\/doi.org\/10.1111\/j.1750-3639.2007.00120.x","journal-title":"Brain Pathol"},{"key":"735_CR63","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1074\/jbc.M110.128157","volume":"286","author":"DC Ng","year":"2011","unstructured":"Ng DC et al (2011) Opposing actions of extracellular signal-regulated kinase (ERK) and signal transducer and activator of transcription 3 (STAT3) in regulating microtubule stabilization during cardiac hypertrophy. J Biol Chem 286:1576\u20131587. https:\/\/doi.org\/10.1074\/jbc.M110.128157","journal-title":"J Biol Chem"},{"key":"735_CR64","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.neulet.2008.11.015","volume":"450","author":"A Ohrfelt","year":"2009","unstructured":"Ohrfelt A, Grognet P, Andreasen N, Wallin A, Vanmechelen E, Blennow K, Zetterberg H (2009) Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss? Neurosci Lett 450:332\u2013335. https:\/\/doi.org\/10.1016\/j.neulet.2008.11.015","journal-title":"Neurosci Lett"},{"key":"735_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006309","volume":"4","author":"D Otaegui","year":"2009","unstructured":"Otaegui D, Baranzini SE, Arma\u00f1anzas R, Calvo B, Mu\u00f1oz-Culla M, Khankhanian P, Inza I, Lozano JA, Castillo-Trivi\u00f1o T, Asensio A, Olaskoaga J, de Munain AL (2009) Differential micro RNA expression in PBMC from multiple sclerosis patients. PLoS One 4:e6309. https:\/\/doi.org\/10.1371\/journal.pone.0006309","journal-title":"PLoS One"},{"issue":"Suppl 3","key":"735_CR66","doi-asserted-by":"publisher","first-page":"S200","DOI":"10.1016\/S1353-8020(09)70814-4","volume":"15","author":"Y Ouchi","year":"2009","unstructured":"Ouchi Y, Yagi S, Yokokura M, Sakamoto M (2009) Neuroinflammation in the living brain of Parkinson's disease. Parkinsonism Relat Disord 15(Suppl 3):S200\u2013S204. https:\/\/doi.org\/10.1016\/S1353-8020(09)70814-4","journal-title":"Parkinsonism Relat Disord"},{"key":"735_CR67","unstructured":"Parkinson's Disease Foundation: Statistics on Parkinson's. (2016)"},{"key":"735_CR68","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s10517-011-1221-3","volume":"150","author":"SN Pchelina","year":"2011","unstructured":"Pchelina SN, Emelyanov AK, Yakimovskii AF, Miller DW, Shabalina IG, Drozdova AS, Schwarzman AL (2011) Reduced content of alpha-synuclein in peripheral blood leukocytes of patients with LRRK2-associated Parkinson's disease. Bull Exp Biol Med 150:679\u2013681. https:\/\/doi.org\/10.1007\/s10517-011-1221-3","journal-title":"Bull Exp Biol Med"},{"key":"735_CR69","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.bbrc.2016.09.114","volume":"479","author":"M Pietrzak","year":"2016","unstructured":"Pietrzak M, Papp A, Curtis A, Handelman SK, Kataki M, Scharre DW, Rempala G, Sadee W (2016) Gene expression profiling of brain samples from patients with Lewy body dementia Biochem. Biophys Res Commun 479:875\u2013880. https:\/\/doi.org\/10.1016\/j.bbrc.2016.09.114","journal-title":"Biophys Res Commun"},{"key":"735_CR70","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/nbm.1176","volume":"21","author":"NG Psihogios","year":"2008","unstructured":"Psihogios NG, Gazi IF, Elisaf MS, Seferiadis KI, Bairaktari ET (2008) Gender-related and age-related urinalysis of healthy subjects by NMR-based metabonomics. NMR Biomed 21:195\u2013207. https:\/\/doi.org\/10.1002\/nbm.1176","journal-title":"NMR Biomed"},{"key":"735_CR71","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.1212\/WNL.0000000000004844","volume":"90","author":"ER Reed","year":"2018","unstructured":"Reed ER, Latourelle JC, Bockholt JH, Bregu J, Smock J, Paulsen JS, Myers RH, PREDICT-HD CSF ancillary study investigators (2018) MicroRNAs in CSF as prodromal biomarkers for Huntington disease in the PREDICT-HD study. Neurology 90:e264\u2013e272. https:\/\/doi.org\/10.1212\/WNL.0000000000004844","journal-title":"Neurology"},{"key":"735_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003652","volume":"3","author":"R Saba","year":"2008","unstructured":"Saba R, Goodman CD, Huzarewich RL, Robertson C, Booth SA (2008) A miRNA signature of prion induced neurodegeneration. PLoS One 3:e3652. https:\/\/doi.org\/10.1371\/journal.pone.0003652","journal-title":"PLoS One"},{"key":"735_CR73","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1111\/j.1460-9568.2012.08220.x","volume":"36","author":"HL Scott","year":"2012","unstructured":"Scott HL, Tamagnini F, Narduzzo KE, Howarth JL, Lee YB, Wong LF, Brown MW, Warburton EC, Bashir ZI, Uney JB (2012) MicroRNA-132 regulates recognition memory and synaptic plasticity in the perirhinal cortex. Eur J Neurosci 36:2941\u20132948. https:\/\/doi.org\/10.1111\/j.1460-9568.2012.08220.x","journal-title":"Eur J Neurosci"},{"key":"735_CR74","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/cen3.12553","volume":"11","author":"M Seamon","year":"2020","unstructured":"Seamon M, Purohit S, Giri B, Baban B, Morgan JC, Chong R, Wakade C (2020) Niacin for Parkinson's disease. Clinical & Experimental Neuroimmunology 11:10","journal-title":"Clinical & Experimental Neuroimmunology"},{"key":"735_CR75","doi-asserted-by":"publisher","first-page":"325","DOI":"10.5607\/en20042","volume":"29","author":"W Seol","year":"2020","unstructured":"Seol W, Kim H, Son I (2020) Urinary biomarkers for neurodegenerative. Diseases Exp Neurobiol 29:325\u2013333. https:\/\/doi.org\/10.5607\/en20042","journal-title":"Diseases Exp Neurobiol"},{"key":"735_CR76","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jamaneurol.2016.4547","volume":"74","author":"M Shahnawaz","year":"2017","unstructured":"Shahnawaz M, Tokuda T, Waragai M, Mendez N, Ishii R, Trenkwalder C, Mollenhauer B, Soto C (2017) Development of a biochemical diagnosis of Parkinson disease by detection of alpha-Synuclein Misfolded aggregates in cerebrospinal fluid. JAMA Neurol 74:163\u2013172. https:\/\/doi.org\/10.1001\/jamaneurol.2016.4547","journal-title":"JAMA Neurol"},{"key":"735_CR77","doi-asserted-by":"crossref","unstructured":"Shalash A et al. (2017) Elevated serum \u03b1-Synuclein autoantibodies in patients with Parkinson\u2019s disease relative to Alzheimer\u2019s disease and controls. Front Neurol","DOI":"10.3389\/fneur.2017.00720"},{"key":"735_CR78","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1002\/mds.25260","volume":"27","author":"TB Sherer","year":"2012","unstructured":"Sherer TB, Chowdhury S, Peabody K, Brooks DW (2012) Overcoming obstacles in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society 27:1606\u20131611. https:\/\/doi.org\/10.1002\/mds.25260","journal-title":"Movement disorders : official journal of the Movement Disorder Society"},{"key":"735_CR79","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10059-000-0065-x","volume":"10","author":"EC Shin","year":"2000","unstructured":"Shin EC, Cho SE, Lee DK, Hur MW, Paik SR, Park JH, Kim J (2000) Expression patterns of alpha-synuclein in human hematopoietic cells and in Drosophila at different developmental stages. Mol Cells 10:65\u201370. https:\/\/doi.org\/10.1007\/s10059-000-0065-x","journal-title":"Mol Cells"},{"key":"735_CR80","first-page":"1153","volume":"71","author":"JA Simerville","year":"2005","unstructured":"Simerville JA, Maxted WC, Pahira JJ (2005) Urinalysis: a comprehensive review. Am Fam Physician 71:1153\u20131162","journal-title":"Am Fam Physician"},{"key":"735_CR81","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/bs.acc.2016.07.003","volume":"78","author":"JM Street","year":"2017","unstructured":"Street JM, Koritzinsky EH, Glispie DM, Star RA, Yuen PS (2017) Urine Exosomes: an emerging trove of biomarkers. Adv Clin Chem 78:103\u2013122. https:\/\/doi.org\/10.1016\/bs.acc.2016.07.003","journal-title":"Adv Clin Chem"},{"key":"735_CR82","doi-asserted-by":"publisher","first-page":"F785","DOI":"10.1152\/ajprenal.00368.2018","volume":"316","author":"IO Sun","year":"2019","unstructured":"Sun IO, Lerman LO (2019) Urinary microRNA in kidney disease: utility and roles. Am J Physiol Renal Physiol 316:F785\u2013F793. https:\/\/doi.org\/10.1152\/ajprenal.00368.2018","journal-title":"Am J Physiol Renal Physiol"},{"key":"735_CR83","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1177\/0271678X18773871","volume":"38","author":"P Sun","year":"2018","unstructured":"Sun P, Liu DZ, Jickling GC, Sharp FR, Yin KJ (2018) MicroRNA-based therapeutics in central nervous system injuries. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 38:1125\u20131148. https:\/\/doi.org\/10.1177\/0271678X18773871","journal-title":"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism"},{"key":"735_CR84","doi-asserted-by":"publisher","unstructured":"Surguchov A (2016) Parkinson's Disease: Assay of Phosphorylated alpha-Synuclein in Skin Biopsy for Early Diagnosis and Association with Melanoma. Brain Sci:6. https:\/\/doi.org\/10.3390\/brainsci6020017","DOI":"10.3390\/brainsci6020017"},{"key":"735_CR85","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/PPO.0b013e318258b5d6","volume":"18","author":"SB Thorsen","year":"2012","unstructured":"Thorsen SB, Obad S, Jensen NF, Stenvang J, Kauppinen S (2012) The therapeutic potential of microRNAs in cancer. Cancer J 18:275\u2013284. https:\/\/doi.org\/10.1097\/PPO.0b013e318258b5d6","journal-title":"Cancer J"},{"key":"735_CR86","doi-asserted-by":"publisher","first-page":"521","DOI":"10.2217\/14796694.3.5.521","volume":"3","author":"E Tili","year":"2007","unstructured":"Tili E, Michaille JJ, Gandhi V, Plunkett W, Sampath D, Calin GA (2007) miRNAs and their potential for use against cancer and other diseases. Future Oncol 3:521\u2013537. https:\/\/doi.org\/10.2217\/14796694.3.5.521","journal-title":"Future Oncol"},{"key":"735_CR87","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1212\/WNL.0b013e3181fd613b","volume":"75","author":"T Tokuda","year":"2010","unstructured":"Tokuda T, Qureshi MM, Ardah MT, Varghese S, Shehab SAS, Kasai T, Ishigami N, Tamaoka A, Nakagawa M, el-Agnaf OMA (2010) Detection of elevated levels of alpha-synuclein oligomers in CSF from patients with Parkinson disease. Neurology 75:1766\u20131772. https:\/\/doi.org\/10.1212\/WNL.0b013e3181fd613b","journal-title":"Neurology"},{"key":"735_CR88","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3389\/fnmol.2017.00329","volume":"10","author":"E Valera","year":"2017","unstructured":"Valera E, Spencer B, Mott J, Trejo M, Adame A, Mante M, Rockenstein E, Troncoso JC, Beach TG, Masliah E, Desplats P (2017) MicroRNA-101 modulates autophagy and Oligodendroglial alpha-Synuclein accumulation in multiple system atrophy. Front Mol Neurosci 10:329. https:\/\/doi.org\/10.3389\/fnmol.2017.00329","journal-title":"Front Mol Neurosci"},{"key":"735_CR89","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.parkreldis.2019.02.014","volume":"63","author":"G Vivacqua","year":"2019","unstructured":"Vivacqua G, Suppa A, Mancinelli R, Belvisi D, Fabbrini A, Costanzo M, Formica A, Onori P, Fabbrini G, Berardelli A (2019) Salivary alpha-synuclein in the diagnosis of Parkinson's disease and progressive Supranuclear palsy. Parkinsonism Relat Disord 63:143\u2013148. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.02.014","journal-title":"Parkinsonism Relat Disord"},{"key":"735_CR90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109818","volume":"9","author":"C Wakade","year":"2014","unstructured":"Wakade C, Chong R, Bradley E, Thomas B, Morgan J (2014) Upregulation of GPR109A in Parkinson's disease. PLoS One 9:e109818. https:\/\/doi.org\/10.1371\/journal.pone.0109818","journal-title":"PLoS One"},{"key":"735_CR91","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jneuroim.2018.05.002","volume":"320","author":"C Wakade","year":"2018","unstructured":"Wakade C, Giri B, Malik A, Khodadadi H, Morgan JC, Chong RK, Baban B (2018) Niacin modulates macrophage polarization in Parkinson's disease. J Neuroimmunol 320:76\u201379. https:\/\/doi.org\/10.1016\/j.jneuroim.2018.05.002","journal-title":"J Neuroimmunol"},{"key":"735_CR92","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ajhg.2007.09.021","volume":"82","author":"G Wang","year":"2008","unstructured":"Wang G, van der Walt JM, Mayhew G, Li YJ, Z\u00fcchner S, Scott WK, Martin ER, Vance JM (2008a) Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. Am J Hum Genet 82:283\u2013289. https:\/\/doi.org\/10.1016\/j.ajhg.2007.09.021","journal-title":"Am J Hum Genet"},{"key":"735_CR93","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fnmol.2020.00053","volume":"13","author":"L Wang","year":"2020","unstructured":"Wang L, Zhang L (2020a) Circulating Exosomal miRNA as diagnostic biomarkers of neurodegenerative diseases. Front Mol Neurosci 13:53. https:\/\/doi.org\/10.3389\/fnmol.2020.00053","journal-title":"Front Mol Neurosci"},{"key":"735_CR94","doi-asserted-by":"publisher","first-page":"111080","DOI":"10.1016\/j.exger.2020.111080","volume":"141","author":"R Wang","year":"2020","unstructured":"Wang R, Zhang J (2020b) Clinical significance of miR-433 in the diagnosis of Alzheimer's disease and its effect on Abeta-induced neurotoxicity by regulating JAK2. Exp Gerontol 141:111080. https:\/\/doi.org\/10.1016\/j.exger.2020.111080","journal-title":"Exp Gerontol"},{"key":"735_CR95","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3389\/fnins.2015.00433","volume":"9","author":"T Wang","year":"2015","unstructured":"Wang T, Hay JC (2015) Alpha-synuclein toxicity in the early secretory pathway: how it drives Neurodegeneration in Parkinsons disease. Front Neurosci 9:433. https:\/\/doi.org\/10.3389\/fnins.2015.00433","journal-title":"Front Neurosci"},{"key":"735_CR96","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1523\/JNEUROSCI.5065-07.2008","volume":"28","author":"WX Wang","year":"2008","unstructured":"Wang WX, Rajeev BW, Stromberg AJ, Ren N, Tang G, Huang Q, Rigoutsos I, Nelson PT (2008b) The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci 28:1213\u20131223. https:\/\/doi.org\/10.1523\/JNEUROSCI.5065-07.2008","journal-title":"J Neurosci"},{"key":"735_CR97","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neulet.2015.05.030","volume":"599","author":"X Wang","year":"2015","unstructured":"Wang X, Yu S, Li F, Feng T (2015) Detection of alpha-synuclein oligomers in red blood cells as a potential biomarker of Parkinson's disease. Neurosci Lett 599:115\u2013119. https:\/\/doi.org\/10.1016\/j.neulet.2015.05.030","journal-title":"Neurosci Lett"},{"key":"735_CR98","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.3390\/ijms11114257","volume":"11","author":"M Waragai","year":"2010","unstructured":"Waragai M, Sekiyama K, Sekigawa A, Takamatsu Y, Fujita M, Hashimoto M (2010) Alpha-Synuclein and DJ-1 as potential biological fluid biomarkers for Parkinson's disease. Int J Mol Sci 11:4257\u20134266. https:\/\/doi.org\/10.3390\/ijms11114257","journal-title":"Int J Mol Sci"},{"key":"735_CR99","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fnmol.2016.00140","volume":"9","author":"Q Wu","year":"2016","unstructured":"Wu Q, Ye X, Xiong Y, Zhu H, Miao J, Zhang W, Wan J (2016) The protective role of microRNA-200c in Alzheimer's disease pathologies is induced by Beta amyloid-triggered endoplasmic reticulum stress. Front Mol Neurosci 9:140. https:\/\/doi.org\/10.3389\/fnmol.2016.00140","journal-title":"Front Mol Neurosci"},{"key":"735_CR100","doi-asserted-by":"publisher","unstructured":"Yu L, Li H, Liu W, Zhang L, Tian Q, Li H, Li M (2020) MiR-485-3p serves as a biomarker and therapeutic target of Alzheimer's disease via regulating neuronal cell viability and neuroinflammation by targeting AKT3. Mol genet genomic med:e1548. https:\/\/doi.org\/10.1002\/mgg3.1548","DOI":"10.1002\/mgg3.1548"},{"key":"735_CR101","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/MPG.0b013e31822200cc","volume":"53","author":"AM Zahm","year":"2011","unstructured":"Zahm AM, Thayu M, Hand NJ, Horner A, Leonard MB, Friedman JR (2011) Circulating microRNA is a biomarker of pediatric Crohn disease. J Pediatr Gastroenterol Nutr 53:26\u201333. https:\/\/doi.org\/10.1097\/MPG.0b013e31822200cc","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"735_CR102","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jocn.2019.04.004","volume":"65","author":"R Zeng","year":"2019","unstructured":"Zeng R, Luo DX, Li HP, Zhang QS, Lei SS, Chen JH (2019) MicroRNA-135b alleviates MPP(+)-mediated Parkinson's disease in in vitro model through suppressing FoxO1-induced NLRP3 inflammasome and pyroptosis. J Clin Neurosci 65:125\u2013133. https:\/\/doi.org\/10.1016\/j.jocn.2019.04.004","journal-title":"J Clin Neurosci"},{"key":"735_CR103","doi-asserted-by":"publisher","first-page":"1743183","DOI":"10.1155\/2019\/1743183","volume":"2019","author":"L Zhao","year":"2019","unstructured":"Zhao L, Wang Z (2019) MicroRNAs: game changers in the regulation of alpha-Synuclein in Parkinson's disease. Parkinsons Dis 2019:1743183\u20131743110. https:\/\/doi.org\/10.1155\/2019\/1743183","journal-title":"Parkinsons Dis"},{"key":"735_CR104","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.3892\/etm.2015.2179","volume":"9","author":"Y Zhu","year":"2015","unstructured":"Zhu Y, Li C, Sun A, Wang Y, Zhou S (2015) Quantification of microRNA-210 in the cerebrospinal fluid and serum: implications for Alzheimer's disease. Exp Ther Med 9:1013\u20131017. https:\/\/doi.org\/10.3892\/etm.2015.2179","journal-title":"Exp Ther Med"},{"key":"735_CR105","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/s0009-8981(97)00110-1","volume":"265","author":"C Zuppi","year":"1997","unstructured":"Zuppi C, Messana I, Forni F, Rossi C, Pennacchietti L, Ferrari F, Giardina B (1997) 1H NMR spectra of normal urines: reference ranges of the major metabolites. Clin Chim Acta 265:85\u201397. https:\/\/doi.org\/10.1016\/s0009-8981(97)00110-1","journal-title":"Clin Chim Acta"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-021-00735-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-021-00735-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-021-00735-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T17:26:43Z","timestamp":1657819603000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-021-00735-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,21]]},"references-count":105,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["735"],"URL":"https:\/\/doi.org\/10.1007\/s11011-021-00735-2","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,21]]},"assertion":[{"value":"31 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}